BMW Group India pledges Rs. 8 crore for CSR efforts to combat Covid-19
BMW Group India has pledged a total of Rs. 8 crore towards the COVID-19 pandemic.
The company’s CSR efforts are dedicated to augmenting healthcare infrastructure and medical services in Gurugram (Delhi NCR) and Chengalpattu (Tamil Nadu).
CSR efforts
Associations with government and non-government organisations have been initiated for on-ground implementation. 150 oxygen concentrators have been imported by the Group for critical care of COVID-19 patients. The concentrators will be utilised by an oxygen bank in Gurugram (Delhi NCR) operated by GiveIndia, a non-governmental organisation.
Vikram Pawah, President, BMW Group India said, “We are fully committed to fighting the COVID-19 pandemic and flattening the curve since its onset. We are also actively involved in critical and immediate relief initiatives such as import of oxygen concentrators that will play a crucial role in saving lives.”
An Isolation Ward and PCR Lab have been created at Chengalpattu Government Hospital with further commitment to provide RT-PCR lab equipment and microbial detection systems to expand COVID-19 testing. The BMW India Foundation has worked closely with Gurugram District Health Administration for sample collection and vaccination programme by providing Mobile Vans and Rapid Antigen Kits.
Critical care equipment has been provided to Gurugram Civil Hospital and an Isolation Ward has been created for police department at Manesar. In both Gurugram (Delhi NCR) and Chennai (Tamil Nadu), frontline health workers and patients have been supported with PPE Kits, face shields and masks. The Foundation has also distributed meals and ration kits to the underprivileged.
BMW Group India Employee Welfare
In addition to the activities undertaken as CSR, BMW Group India is ensuring safety and welfare of its employees and their families.
The company has tied-up with leading hospitals for vaccination of associates and their families at the Training Centre in Gurugram (Delhi NCR) and BMW Group Plant Chennai in Chengalpattu (Tamil Nadu).
A ‘Doctor-On-Call’ facility covers prevention, home testing, consultation, treatment and ambulance services tie-up for COVID-19. This also includes professional assistance for overall well-being and stress-related issues caused due to the current situation.
Disclaimer: This media release is auto-generated. The CSR Journal is not responsible for the content
